Zhang, Tingting
Lou, Mingxing
Li, Xinglou
Wang, Yuchang
Li, Peichun
Article History
Received: 4 August 2025
Accepted: 30 November 2025
First Online: 3 February 2026
Declarations
:
: The initial study was approved by the Rich Healthcare Group Review Board, which waived the requirement for informed consent. No additional approval from the institutional review board was necessary for the secondary analysis. This study was conducted in accordance with the principles outlined in the Declaration of Helsinki, ensuring compliance with all relevant ethical guidelines and regulatory standards.
: The authors declare no competing interests.